{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:52:28Z","timestamp":1790887948123,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.autrev.2011.05.011","type":"journal-article","created":{"date-parts":[[2011,5,22]],"date-time":"2011-05-22T17:11:36Z","timestamp":1306084296000},"page":"191-195","source":"Crossref","is-referenced-by-count":44,"title":["Autoimmune diseases of the peripheral nervous system"],"prefix":"10.1016","volume":"11","author":[{"given":"Bernd C.","family":"Kieseier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmar C.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd Meyer zu","family":"H\u00f6rste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2011.05.011_bb0005","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1750-3639.1999.tb00231.x","article-title":"Mechanisms of immune regulation in the peripheral nervous system","volume":"9","author":"Gold","year":"1999","journal-title":"Brain Pathol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mus.20076","article-title":"Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system","volume":"30","author":"Kieseier","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2011.05.011_bb0015","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/eji.1830161214","article-title":"Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes","volume":"16","author":"Wekerle","year":"1986","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00019052-200210000-00013","article-title":"Animal models of immune-mediated neuropathies","volume":"15","author":"M\u00e4urer","year":"2002","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0025","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00005072-199311000-00001","article-title":"Macrophage systems in peripheral nerves. A review","volume":"52","author":"Griffin","year":"1993","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0301-0082(00)00060-5","article-title":"The role of macrophages in immune-mediated damage to the peripheral nervous system","volume":"64","author":"Kiefer","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0035","series-title":"In Clinical Neuroimmunology","first-page":"77","article-title":"Immunological properties of the peripheral nervous system","author":"Gold","year":"2005"},{"key":"10.1016\/j.autrev.2011.05.011_bb0040","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1750-3639.1999.tb00231.x","article-title":"Mechanisms of immune regulation in the peripheral nervous system","volume":"9","author":"Gold","year":"1999","journal-title":"Brain Pathol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.coi.2004.12.004","article-title":"Antigen presentation and recognition in bacterial infections","volume":"17","author":"Kaufmann","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0050","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nri1631","article-title":"Recognition of lipid antigens by T cells","volume":"5","author":"De Libero","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0055","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2011.05.011_bb0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1473-3099(01)00019-6","article-title":"Infectious origins of, and molecular mimicry in, Guillain-Barr\u00e9 and Fisher syndromes","volume":"1","author":"Yuki","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.autrev.2011.05.011_bb0065","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1085-9489.2005.0010202.x","article-title":"The immunobiology of Guillain-Barre syndromes","volume":"10","author":"Willison","year":"2005","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.autrev.2011.05.011_bb0070","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00019052-199908000-00006","article-title":"Advances in chronic inflammatory demyelinating polyneuropathy: disease variants and inflammatory response mediators and modifiers","volume":"12","author":"Dalakas","year":"1999","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1212\/WNL.40.2.215","article-title":"T cell activation in Guillain-Barr\u00e9 syndrome and in MS: elevated serum levels of soluble IL-2 receptors","volume":"40","author":"Hartung","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2011.05.011_bb0080","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.410300110","article-title":"Serum interleukin-2 concentrations in the Guillain-Barr\u00e9 syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis","volume":"30","author":"Hartung","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0085","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/jnnp.2004.052282","article-title":"T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"76","author":"Csurhes","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2011.05.011_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2006.05.018","article-title":"Susceptibility to Guillain-Barre syndrome is associated to polymorphisms of CD1 genes","author":"Caporale","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0095","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jocn.2004.04.006","article-title":"Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain-Barre syndrome","volume":"12","author":"Csurhes","year":"2005","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.autrev.2011.05.011_bb0100","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMra041347","article-title":"Chronic inflammatory demyelinating polyneuropathy","volume":"352","author":"Koller","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2011.05.011_bb0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1212\/WNL.56.1.74","article-title":"Sural nerve T-cell receptor Vbeta gene utilization in chronic inflammatory demyelinating polyneuropathy and vasculitic neuropathy","volume":"56","author":"Bosboom","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2011.05.011_bb0110","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.4049\/jimmunol.164.8.4375","article-title":"Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy","volume":"164","author":"Illes","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0115","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<474::AID-MUS8>3.0.CO;2-9","article-title":"Inflammatory infiltrates in sural nerve biopsies in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating neuropathy","volume":"19","author":"Schmidt","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2011.05.011_bb0120","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s004150200072","article-title":"gammadelta T cells infiltrating sensory nerve biopsies from patients with inflammatory neuropathy","volume":"249","author":"Winer","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/intimm\/dxh018","article-title":"Accumulation of Valpha7.2-Jalpha33 invariant T cells in human autoimmune inflammatory lesions in the nervous system","volume":"16","author":"Illes","year":"2004","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0301-0082(00)00045-9","article-title":"Role of integrins in the peripheral nervous system","volume":"64","author":"Previtali","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0135","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ana.410440406","article-title":"Expression of integrins in experimental autoimmune neuritis and Guillain-Barre syndrome","volume":"44","author":"Previtali","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0140","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/brain\/awf070","article-title":"Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10","volume":"125","author":"Kieseier","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2011.05.011_bb0145","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/01.wco.0000169744.14288.d1","article-title":"Chronic inflammatory demyelinating polyneuropathy\u2013update on pathogenesis, diagnostic criteria and therapy","volume":"18","author":"Koller","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0150","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00415-005-0805-0","article-title":"Treatment of dys-immune neuropathies","volume":"252","author":"Nobile-Orazio","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0155","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/mus.20391","article-title":"Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment","volume":"32","author":"Jann","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2011.05.011_bb0160","doi-asserted-by":"crossref","first-page":"245-245","DOI":"10.1016\/S1474-4422(10)70021-1","article-title":"Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial","volume":"9","author":"van Schaik","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0165","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/01.wco.0000175937.31569.15","article-title":"Multifocal motor neuropathy","volume":"18","author":"Leger","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0170","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.wco.0000245364.51823.3b","article-title":"The inflamed peripheral nervous system: update on immune therapies","volume":"19","author":"Kieseier","year":"2006","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2011.05.011_bb0175","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archneurol.2010.143","article-title":"Natalizumab treatment in a patient with chronic inflammatory demyelinating polyneuropathy","volume":"67","author":"Wolf","year":"2010","journal-title":"Arch Neurol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211001133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211001133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T02:11:33Z","timestamp":1560219093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997211001133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1568997211001133"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2011.05.011","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}